TSplus Introduces New Feedback & Roadmap Platform to Enhance the Remote Desktop User Experience
Think Business, Think Hong Kong strengthens Italy-Hong Kong ties and opens new path for Asian collaboration
FUTR Announces Q1 2026 Financial Results
Tenet Reports Third Quarter 2025 Financial Results
Eguana Announces Third Quarter 2025 Financial Results
European Commission decision anticipated in July BOSTON, May 21, 2021 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals,…
– Bylvay has the potential to become first approved drug to treat all forms of…
EMERYVILLE, Calif., May 21, 2021 (GLOBE NEWSWIRE) — Biofacturing leader Zymergen today announced the company will…
CHMP opinion recommending approval based on data from the Phase 3 LIBERTY program in women…
NEW YORK, May 21, 2021 (GLOBE NEWSWIRE) — NetworkNewsAudio – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB:…
PMN310 potential best in class antibody candidate for treatment of Alzheimer’s disease TORONTO and CAMBRIDGE,…
CAMBRIDGE, Mass., May 21, 2021 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”), an…
EMERYVILLE, Calif., May 21, 2021 (GLOBE NEWSWIRE) — XOMA Corporation (Nasdaq: XOMA) recently learned its…
European Key Opinion Leaders to Participate in Event REDWOOD CITY, Calif., May 21, 2021 (GLOBE…
SUZHOU, China and PALO ALTO, Calif., May 21, 2021 (GLOBE NEWSWIRE) — Gracell Biotechnologies Inc….
Laboratory and pre-clinical models of whole-lung engineering inform roadmap for building a functional lung alveolus,…
Provides educational resources for both patients and healthcare providers SAN DIEGO, May 21, 2021 (GLOBE…
Collaboration aims to develop a next-generation AAV production platform to help accelerate Biogen’s efforts to…
JENA, Germany, May 21, 2021 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical…
DUBLIN, Ireland and KING OF PRUSSIA, Pa., May 21, 2021 (GLOBE NEWSWIRE) — Nabriva Therapeutics…
MALVERN, Pa., May 21, 2021 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”), a commercial-stage medical…
PHILADELPHIA, May 21, 2021 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD), today announced two posters…
Attendance in person is not permitted LONDON, May 21, 2021 (GLOBE NEWSWIRE) — Autolus Therapeutics…
NX-5948, a potent selective degrader of BTK, significantly reduces inflammation in a model of autoimmune…
BioNTech is committed to contributing to the UN Sustainable Development Goals (SDGs), particularly the promotion…